Back
Aprea Therapeutics Stock Price Chart
Sponsored
APRE
Sponsored
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
APRE
Aprea Therapeutics
Last Price:
2.60
Seasonality Move:
-39.53%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APRE is experiencing selling pressure, which indicates risk of future bearish movement.
Aprea Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.73 | Sell |
20-day SMA: | 2.96 | Sell |
50-day SMA: | 3.31 | Sell |
200-day SMA: | 4.86 | Sell |
8-day EMA: | 2.74 | Sell |
20-day EMA: | 2.94 | Sell |
50-day EMA: | 3.3 | Sell |
200-day EMA: | 4.5 | Sell |
Aprea Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.21 | Sell |
Relative Strength Index (14 RSI): | 33.15 | Sell |
Chaikin Money Flow: | -13903 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.78 - 3.32) | Sell |
Bollinger Bands (100): | (3.14 - 4.58) | Sell |
Aprea Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aprea Therapeutics Stock
Is Aprea Therapeutics Stock a Buy?
- Aprea Therapeutics share price is 2.60 while APRE 8-day simple moving average is 2.73, which is a Sell signal.
- The stock price of APRE is 2.60 while Aprea Therapeutics 20-day SMA is 2.96, which makes it a Sell.
- Aprea Therapeutics 50-day simple moving average is 3.31 while APRE share price is 2.60, making it a Sell technically.
- APRE stock price is 2.60 and Aprea Therapeutics 200-day simple moving average is 4.86, creating a Sell signal.
APRE Technical Analysis vs Fundamental Analysis
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Is Aprea Therapeutics a Buy or a Sell?
-
Aprea Therapeutics stock is rated a Sell
The current Aprea Therapeutics [APRE] share price is $2.60. The Score for APRE is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Aprea Therapeutics Stock Info
Market Cap:
14.12M
Price in USD:
2.60
Share Volume:
13.9K
Aprea Therapeutics 52-Week Range
52-Week High:
8.85
52-Week Low:
2.25
Sell
30
Aprea Therapeutics (APRE)
is a Sell
Aprea Therapeutics Share Price Forecast
-
What is the Aprea Therapeutics stock price today?
The Aprea Therapeutics stock price is 2.60 USD today. -
Will APRE stock go up or go down?
Aprea Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aprea Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aprea Therapeutics is overvalued.
Is Aprea Therapeutics Stock a Buy?
- Aprea Therapeutics share price is 2.60 while APRE 8-day exponential moving average is 2.74, which is a Sell signal.
- The stock price of APRE is 2.60 while Aprea Therapeutics 20-day EMA is 2.94, which makes it a Sell.
- Aprea Therapeutics 50-day exponential moving average is 3.30 while APRE share price is 2.60, making it a Sell technically.
- APRE stock price is 2.60 and Aprea Therapeutics 200-day simple moving average is 4.50, creating a Sell signal.
Fundamental Analysis of Aprea Therapeutics
Is Aprea Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and an increase next year of $2.56 per share.
Technical Analysis of Aprea Therapeutics
Should I short Aprea Therapeutics stock?
- APRE Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Aprea Therapeutics is a Sell
- Aprea Therapeutics Relative Strength Index (RSI) is 33.15, which suggest Aprea Therapeutics is oversold
- The Bollinger Bands (25) for Aprea Therapeutics is (2.78 - 3.32), which suggest Aprea Therapeutics is a Sell
- The Bollinger Bands (100) for Aprea Therapeutics is (3.14 - 4.58), which suggest Aprea Therapeutics is a Sell
* Aprea Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.